 |
Technical Data |
|
J2600 |
JNK2 alpha2, active, Recombinant, Human (c-Jun N-terminal Kinase 2, JNK2, JNK2alpha, JNK2A, JNK-55, Mitogen-activated Protein Kinase 9, MAP Kinase 9, MAPK 9, MAPK9, PRKM9, p54a, p54aSAPK, Stress-activated Protein Kinase 1a, SAPK1a, SAPK, Stress-activated |
10ug |
| Molecular Biology | Storage: -70°CShipping: Dry Ice |
|
N-terminal His-tagged, full-length human JNK2a2/SAPK1a expressed in Sf21 cells. Accession number L31951. JNK2a2 Kinase Assay: JNK2a2 activity was measured using GST-ATF2 as substrate in the kinase assay. Specific Activity: 80u/mg where one unit of JNK2a2 activity is equal to 1nmol phosphate incorporated into GST-ATF2 per minute. Molecular Weight: 51kD MS Tryptic Fingerprint:Confirmed as JNK2alpha2/SAPK1a with sequence coverage from 11 peptides, 117-424 aa. Storage and Stability: Stable for 6 months at -70°C from date of shipment. Molecular Weight: 51kD |
Source: Recombinant human Purity: 90%. Purified using Ni-NTA agarose. Mr ~51kD (SDS-PAGE and Coomassie Stain) Form: Supplied as a frozen solution in 60ul of 50mM Tris-HCl, pH 7.5, 270mM sucrose, 150mM NaCl, 0.1mM EGTA, 0.1% 2-mercaptoethanol, 0.2mM PMSF, 0.03% Brij-35, 1mM benzamidine Intended for research use only, not for use in human, therapeutic or diagnostic applications. |
|
1. Gupta, S., et al., EMBO J. 15: 2760–2770, 1996. 2. Gupta, S., et al., Science 267: 389–393, 1995. 3. Lawler, S., et al., FEBS Lett 414: 153–158, 1997.
|
||